Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TTRX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTurn Therapeutics files routine 8-K with undisclosed press release content
Filed May 19, 2026 · Period ending May 19, 2026 · ~1 min read
Key Changes
-
low
Company issued a press release on May 19, 2026, furnished under Regulation FD disclosure rules. The 8-K filing does not describe the content of the press release, which is attached as Exhibit 99.1.
Item 7.01 verify on EDGAR →
Summary
Turn Therapeutics filed a Form 8-K on May 19, 2026, disclosing that it issued a press release the same day under Regulation FD. The filing is procedural in nature, with the press release attached as Exhibit 99.1 but no description of its content provided in the 8-K body itself. For retail investors, this filing offers limited actionable information without access to the actual press release content.
The use of Item 7.01 (Regulation FD Disclosure) typically indicates voluntary disclosure of information to comply with fair disclosure rules, but the materiality cannot be assessed from this filing alone. Investors should review the actual press release (Exhibit 99.1) to understand what information the company disclosed. The nature of that content will determine whether any follow-up action or monitoring is warranted.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
On May 19, 2026, Turn Therapeutics Inc. issued a press release (the “Press Release”). A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The company issued a press release on May 19, 2026, which is attached as Exhibit 99.1.Without the exhibit content, the materiality and investor impact cannot be determined from this filing alone.
Event · Item 9.01 — Financial Statements and Exhibits
Turn Therapeutics filed an 8-K attaching a press release dated May 19, 2026; no material business event disclosed in the filing body.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
99.1
Press Release, dated May 19, 2026
The company attached a press release dated May 19, 2026 as Exhibit 99.1. The 8-K body does not describe the content of the press release, so the nature of the disclosure cannot be determined from this filing alone.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify